Fasitibant

DB15646InvestigationalSmall molecule

Fasitibant is under investigation in clinical trial NCT02205814 (Fasitibant Intra-articular Injection in Patients With Symptomatic Osteoarthritis of the Knee).

Chemical structure of Fasitibant
Mechanism
Curator reviewed
Formula / weight
C36H49Cl2N6O6S · 764.78 g/mol (avg)

Resolves to

Structure
InChIKeyFQVSDHOWSLEEKJ-LJAQVGFWSA-NSMILESCC1=NC2=C(C=CC=C2OCC2=C(Cl)C=CC(=C2Cl)S(=O)(=O)NC2(CCOCC2)C(=O)N2CCN(CC2)C(=O)[C@@H](N)CCC[N+](C)(C)C)C(C)=C1

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
6+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Fasitibant, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account